Vijayvergia, Namrata http://orcid.org/0000-0001-6469-4759
Dasari, Arvind
Funding for this research was provided by:
National Cancer Institute (Cancer Center Support Grant (CCSG) P30 CA006927.)
Article History
Accepted: 25 September 2020
First Online: 7 October 2020
Compliance with Ethical Standards
:
: Namrata Vijayvergia has received research funding from Merck for an MISP clinical trial grant, and has received compensation from Lexicon and Novartis for service as a consultant. Arvind Dasari declares that he has no conflict of interest.